Header Logo

Connection

REYNOLDS DELGADO to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications REYNOLDS DELGADO has written about Drug Evaluation, Preclinical.
REYNOLDS DELGADO
Connection Strength
0.053
Drug Evaluation, Preclinical
  1. Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure. Circulation. 2004 Mar 23; 109(11):1428-33.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.